Psyber, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Psyber, Inc. - overview
Location
Dover, DE, US
Primary Industry
Software
About
Based in Delaware, US, and founded in 2021, Psyber, Inc. operates as a developer of brain-computer interface-enabled (BCI) digital therapeutics with psychedelics for the treatment of mental health issues. The company was co-founded by CEO Prahlad Krishnan and COO Ashwin Chandrasekaran. In 2021, atai Life Sciences N.
V. acquired a majority stake in the company. Psyber, Inc. provides its BCI-assisted therapy where the electroencephalogram (EEG)-based BCI devices record the electrical activity in the brain of a patient who is prescribed medication.
The devices provide real-time interpretation of the patient's emotional, behavioral, and mental experiences that complement their medication-assisted therapy. The company plans to develop an EEG-based BCI tailored software platform combined with atai Life Sciences N. V. diverse compounds.
Current Investors
atai Life Sciences N.V.
Primary Industry
Software
Sub Industries
Healthcare IT, Medical Software
Website
www.psyberhealth.com
Verticals
HealthTech
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.